Business

The Grünenthal Group will acquire rights to all dosage forms of Zomig zolmitriptan for the treatment of migraines and cluster headaches, including Zomig nasal spray, from AstraZeneca for $200 million up front plus up to $102 million in future milestone payments the company said. The deal includes rights to market Zomig in all countries where it is approved except … [Read more...] about Grünenthal acquires global rights to Zomig nasal spray

Egalet Corporation has announced that Ascend Therapeutics will begin co-promoting Egalet's Sprix ketorolac tromethamine nasal spray to women's healthcare practitioners in the US in the third quarter of 2017 and will continue for at least two years. Financial terms of the deal were not disclosed. Sprix nasal spray was approved for the short term management of … [Read more...] about Ascend Therapeutics to co-promote Sprix ketorolac nasal spray

US grocer Albertsons will begin selling Lupin's InspiraChamber antistatic valved holding chamber exclusively in more than 1,700 pharmacies in 35 US states, Lupin has announced. The InspiraChamber spacer can be used with one of several pediatric face masks, including the SootherMask, which includes an opening for a child's pacifier. Lupin licensed the product from … [Read more...] about Albertsons to sell Lupin’s InspiraChamber exclusively in US

Horizon Pharma has agreed to sell Raptor Pharmaceuticals, which owns the rights to Quinsair levofloxacin inhalation solution in Europe, the Middle East and Africa, to Chiesi Farmaceutici for $70 million and potential sales-based milestone payments, the company said. Horizon will retain rights to Quinsair and another product, Procysbi, in the US, Canada, and Latin … [Read more...] about Chiesi to acquire Raptor Pharmaceuticals and its rights to Quinsair levofloxacin inhalation solution in EMEA regions

Windtree Therapeutics has received $900,000 from a Small Business Innovation Research Grant (SBIR) grant for Phase 2b trial of Aerosurf aerosolized KL4 surfactant in premature infants with respiratory distress syndrome (RDS) who are receiving nasal continuous positive airway pressure (nCPAP), the company said. In August 2016, Windtree announced that it had … [Read more...] about Windtree Therapeutics gets $900,000 from SBIR grant

Pharmaxis has announced that Chiesi Farmaceutici will take over marketing and distribution of Bronchitol mannitol DPI in Italy. Bronchitol has been approved in the EU for the treatment of cystic fibrosis in patients 18 years old and older since 2012. In 2015, Pharmaxis and Chiesi announced an agreement for distribution rights to Bronchitol in the UK, Ireland, and … [Read more...] about Chiesi to distribute Pharmaxis’s Bronchitol mannitol DPI in Italy

Pulmatrix has announced the receipt of US patent No. 9,642,798, titled "Monovalent metal cation dry powders for inhalation," which covers its PUR0200 dry powder formulation of tiotropium bromide for the treatment of COPD. In July 2016, Pulmatrix announced positive Phase 1 results for PUR0200. The company has previously received a number of patents for its iSPERSE … [Read more...] about Pulmatrix gets US patent covering PUR0200 tiotropium bromide formulation

According to intranasal drug developer OptiNose, the company has raised $37 million in a Series D financing round led by Fidelity Management and Research Company. The company said that it plans to use the money to prepare for the US launch of OPN-375 intranasal fluticasone propionate if approved. OptiNose submitted an NDA for OPN-375 for the treatment of nasal … [Read more...] about OptiNose raises $37 million to prepare for launch of OPN-375

Innovus Pharmaceuticals will launch a fluticasone propionate nasal spray under the brand name FlutiCare in the US by the end of 2017 after acquiring rights to the product from West-Ward Pharmaceuticals International Limited (WWPIL). The 50μg per spray FlutiCare is equivalent to GSK's Flonase, and the company said that it expects revenue from sales of the product in … [Read more...] about Innovus Pharmaceuticals acquires US rights to fluticasone propionate nasal spray from West-Ward